Administration of Hydrogen-Rich Saline in Mice with Allogeneic Hematopoietic Stem-Cell Transplantation
Yuan L, Chen X, Qian L, Shen J, Cai J. · Medical science monitor : international medical journal of experimental and clinical research. 2015;21:749-754.
What kind of evidence is this?
Preclinical
Controlled animal and cell study
Exercise and recovery
Other forms
Not reported in this record.
Not reported in this record.
Methods at a glance
mice, cells, tissue, cell used to study exercise and recovery.
Preclinical study; the article does not state one consolidated sample total, so no total is inferred.
30 days
Full text reports H₂ dissolved in saline. Detected intervention quantities or schedules: 0.9%, 0.6 mmol/L, 5 ml/kg, 30 days.
H₂ dissolved in saline — H₂ only unless the full text explicitly reports oxygen co-delivery.
H₂-related quantities reported in the intervention passages: 0.9%, 0.6 mmol/L, 5 ml/kg, 30 days. Values are not combined across different experimental arms.
Not applicable — no inhaled H₂ intervention was identified in the full article.
No inhaled O₂ co-delivery was identified for this non-inhalation intervention.
Control or comparison condition reported in the full article; see the linked methods for arm-specific details.
Outcomes and reported result
survival or mortality, clinical symptoms or functional scores, inflammation and cytokines, oxidative-stress and antioxidant markers, apoptosis or cell injury, histology or tissue damage
Article-reported result excerpt (24 words maximum): “Forty percent of aGVHD mice with physiologic saline treatment survived to the 18^th day after BMT, and 90% of the mice with hydrogen-rich saline…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.
The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.
A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.
Cautions and applicability
Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The full article contains a conflict, commercial-support or supplied-product declaration; consult the source wording.
Applies to the reported animal, cell or tissue model, not directly to patients.
Not reported in this record.
Not reported in this record.
Not reported in this record.
No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.
Sources and record status
PMID: 25763677 · DOI: 10.12659/msm.891338
A free full article is available through PubMed Central.
Official Europe PMC JATS full article and PubMed/PMC identifiers; structured full-text extraction and validation completed 8 August 2026.
2026-08-10